
Two Seas Capital, Core Scientific’s largest shareholder, will vote against CoreWeave’s $9B buyout, calling it undervalued and risky for investors.

Two Seas Capital, Core Scientific’s largest shareholder, will vote against CoreWeave’s $9B buyout, calling it undervalued and risky for investors.